Ελληνικά
EnglishEstablished to bridge scientific discovery and clinical application, Athens LifeTech Park aims to advance drug discovery and development for the benefit of patients worldwide, by providing a nurturing environment for biotech companies developing the next generation of breakthrough therapies.
Offering state-of-the-art infrastructure and sophisticated R&D support, ALTP’s biotech incubator is designed to advance innovation in a collaborative, cost-effective and globally connected ecosystem.
The new Board of Directors of the Athens LifeTech Park is composed of:
- Kleanthis G. Xanthopoulos, PhD, Chairman of the Board
- Eleni Pentafragka, LLB, MSc, Executive Vice Chairwoman of the Board
- Dimitris Agrafiotis, PhD, FRSC, Board Member
- Konstantina Katcheves, MS, JD, Board Member
- Dimitris Tryfon, BSc, Board Member
Dr. Kleanthis G. Xanthopoulos, Ph.D, Chairman of the Board of Athens LifeTech Park stated: “The Athens LifeTech Park marks a pivotal milestone in the evolution of Greece’s health sciences ecosystem, a launchpad for pioneering companies and transformative ideas. I’m truly excited to collaborate with the distinguished members of the Board and the Park’s talented team to further advance biotechnology and pharmaceutical innovation in Greece and the broader Mediterranean Region.”
Mrs. Eleni Pentafragka, Executive Vice Chairwoman of the Board of Athens LifeTech Park mentioned: “I warmly welcome the new Board of Directors, whose formation marks a significant milestone for the next phase of development of Athens LifeTech Park. By investing in drug discovery and development services and infrastructure, we are laying the foundations for Greece’s stronger role in the global biotechnology landscape. The Board of Directors, with its strategic insight and the valuable experience of its members, strengthens our ability to identify and leverage international opportunities”
